Hemoadsorption Treatment with CytoSorb (R) in Probable Hemophagocytic Lymphohistiocytosis: A Role as Adjunctive Therapy?

Ceruti, Samuele ✉; Glotta, Andrea; Adamson, Harriet; Mauri, Romano; Molnar, Zsolt [Molnár, Zsolt (Klinikai orvostud...), szerző] Aneszteziológiai és Intenzív Terápiás Klinika (SE / AOK / K)

Angol nyelvű Szakcikk (Folyóiratcikk) Tudományos
Megjelent: CASE REPORTS IN HEMATOLOGY 2090-6560 2090-6579 2021 Paper: 5539126 , 5 p. 2021
    Azonosítók
    Acute hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease, with an annual incidence of 1 : 800,000 people. The disease is characterized by a cytokine storm, with concomitant macrophage and natural killer (NK) cell activation; death can occur from multiple organ failure or complications such as bleeding diathesis. Therefore, HLH treatment remains a challenging one. We hereby present a case of a 76-year-old man with severe HLH in whom hemoadsorption was successfully applied. Due to the failure of the immunomodulatory therapy , continuous venovenous hemodiafiltration therapy with the CytoSorb (R) adsorber was successfully applied for 48 hours. Upon therapy discontinuation, the biological and clinical condition reverted, unfortunately evolving towards the patient's death.
    Hivatkozás stílusok: IEEEACMAPAChicagoHarvardCSLMásolásNyomtatás
    2025-03-30 07:25